En Carta Diagnostics raised €1.5M in a funding round in May 2024. The company is based in Paris, France. Investors in the round: CentraleSupélec Venture. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €1.5M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
